These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15922357)

  • 1. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
    Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
    J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of Locusta migratoria protease inhibitor 3 (LMPI-3) in complex with Fusarium oxysporum trypsin.
    Leone P; Roussel A; Kellenberger C
    Acta Crystallogr D Biol Crystallogr; 2008 Nov; 64(Pt 11):1165-71. PubMed ID: 19020355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same fold with different mobility: backbone dynamics of small protease inhibitors from the desert locust, Schistocerca gregaria.
    Szenthe B; Gáspári Z; Nagy A; Perczel A; Gráf L
    Biochemistry; 2004 Mar; 43(12):3376-84. PubMed ID: 15035609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator.
    Song HK; Suh SW
    J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
    Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
    J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of trypsins by insect peptides: role of P6-P10 loop.
    Kellenberger C; Ferrat G; Leone P; Darbon H; Roussel A
    Biochemistry; 2003 Nov; 42(46):13605-12. PubMed ID: 14622007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
    J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme:substrate hydrogen bond shortening during the acylation phase of serine protease catalysis.
    Fodor K; Harmat V; Neutze R; Szilágyi L; Gráf L; Katona G
    Biochemistry; 2006 Feb; 45(7):2114-21. PubMed ID: 16475800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8A resolution.
    Zhu Y; Huang Q; Chi C
    J Biomol Struct Dyn; 1999 Jun; 16(6):1219-24. PubMed ID: 10447205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remarkable phylum selectivity of a Schistocerca gregaria trypsin inhibitor: the possible role of enzyme-inhibitor flexibility.
    Patthy A; Amir S; Malik Z; Bódi A; Kardos J; Asbóth B; Gráf L
    Arch Biochem Biophys; 2002 Feb; 398(2):179-87. PubMed ID: 11831848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold adaption of enzymes: structural comparison between salmon and bovine trypsins.
    Smalås AO; Heimstad ES; Hordvik A; Willassen NP; Male R
    Proteins; 1994 Oct; 20(2):149-66. PubMed ID: 7846025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When the surface tells what lies beneath: combinatorial phage-display mutagenesis reveals complex networks of surface-core interactions in the pacifastin protease inhibitor family.
    Szenthe B; Patthy A; Gáspári Z; Kékesi AK; Gráf L; Pál G
    J Mol Biol; 2007 Jun; 370(1):63-79. PubMed ID: 17499271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
    J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.